IMERYS SA (NK.PA) Fundamental Analysis & Valuation

EPA:NK • FR0000120859

Current stock price

20.68 EUR
-0.34 (-1.62%)
Last:

This NK.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. NK.PA Profitability Analysis

1.1 Basic Checks

  • In the past year NK has reported negative net income.
  • In the past year NK had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: NK reported negative net income in multiple years.
  • Each year in the past 5 years NK had a positive operating cash flow.
NK.PA Yearly Net Income VS EBIT VS OCF VS FCFNK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

  • The Return On Assets of NK (-6.64%) is worse than 86.67% of its industry peers.
  • NK has a worse Return On Equity (-15.72%) than 93.33% of its industry peers.
  • The Return On Invested Capital of NK (3.13%) is worse than 86.67% of its industry peers.
  • NK had an Average Return On Invested Capital over the past 3 years of 3.45%. This is below the industry average of 7.33%.
Industry RankSector Rank
ROA -6.64%
ROE -15.72%
ROIC 3.13%
ROA(3y)-2.45%
ROA(5y)-0.22%
ROE(3y)-5.66%
ROE(5y)-0.47%
ROIC(3y)3.45%
ROIC(5y)3.92%
NK.PA Yearly ROA, ROE, ROICNK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • The Operating Margin of NK (6.70%) is worse than 80.00% of its industry peers.
  • In the last couple of years the Operating Margin of NK has declined.
  • Looking at the Gross Margin, with a value of 67.02%, NK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • NK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.7%
PM (TTM) N/A
GM 67.02%
OM growth 3Y-12.06%
OM growth 5Y-4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.57%
GM growth 5Y2.71%
NK.PA Yearly Profit, Operating, Gross MarginsNK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NK.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NK is destroying value.
  • NK has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NK has less shares outstanding
  • The debt/assets ratio for NK is higher compared to a year ago.
NK.PA Yearly Shares OutstandingNK.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
NK.PA Yearly Total Debt VS Total AssetsNK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • NK has an Altman-Z score of 1.69. This is a bad value and indicates that NK is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.69, NK is doing worse than 66.67% of the companies in the same industry.
  • The Debt to FCF ratio of NK is 19.65, which is on the high side as it means it would take NK, 19.65 years of fcf income to pay off all of its debts.
  • NK has a worse Debt to FCF ratio (19.65) than 86.67% of its industry peers.
  • A Debt/Equity ratio of 0.83 indicates that NK is somewhat dependend on debt financing.
  • The Debt to Equity ratio of NK (0.83) is worse than 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 19.65
Altman-Z 1.69
ROIC/WACC0.48
WACC6.51%
NK.PA Yearly LT Debt VS Equity VS FCFNK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • NK has a Current Ratio of 2.46. This indicates that NK is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.46, NK belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
  • NK has a Quick Ratio of 1.64. This is a normal value and indicates that NK is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.64, NK is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 1.64
NK.PA Yearly Current Assets VS Current LiabilitesNK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NK.PA Growth Analysis

3.1 Past

  • The earnings per share for NK have decreased strongly by -323.05% in the last year.
  • NK shows a decrease in Revenue. In the last year, the revenue decreased by -6.14%.
  • NK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.29% yearly.
EPS 1Y (TTM)-323.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.65%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-7.55%
Revenue growth 5Y-2.29%
Sales Q2Q%-3.51%

3.2 Future

  • Based on estimates for the next years, NK will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.78% on average per year.
  • Based on estimates for the next years, NK will show a small growth in Revenue. The Revenue will grow by 7.26% on average per year.
EPS Next Y16.63%
EPS Next 2Y13.54%
EPS Next 3Y19.78%
EPS Next 5YN/A
Revenue Next Year3.08%
Revenue Next 2Y2.87%
Revenue Next 3Y3.78%
Revenue Next 5Y7.26%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NK.PA Yearly Revenue VS EstimatesNK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
NK.PA Yearly EPS VS EstimatesNK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. NK.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NK. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 9.83 indicates a reasonable valuation of NK.
  • 66.67% of the companies in the same industry are more expensive than NK, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of NK to the average of the S&P500 Index (23.28), we can say NK is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.83
NK.PA Price Earnings VS Forward Price EarningsNK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • NK's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NK is cheaper than 73.33% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, NK is valued a bit more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.45
EV/EBITDA 5.16
NK.PA Per share dataNK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as NK's earnings are expected to grow with 19.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.54%
EPS Next 3Y19.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. NK.PA Dividend Analysis

5.1 Amount

  • NK has a Yearly Dividend Yield of 3.57%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.67, NK pays a better dividend. On top of this NK pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, NK pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.57%

5.2 History

  • The dividend of NK decreases each year by -2.74%.
Dividend Growth(5Y)-2.74%
Div Incr Years1
Div Non Decr Years1
NK.PA Yearly Dividends per shareNK.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • The earnings of NK are negative and hence is the payout ratio. NK will probably not be able to sustain this dividend level.
DP-30.16%
EPS Next 2Y13.54%
EPS Next 3Y19.78%
NK.PA Yearly Income VS Free CF VS DividendNK.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

More info and screens

Find the best dividend stocksShow peers with best dividend

NK.PA Fundamentals: All Metrics, Ratios and Statistics

IMERYS SA

EPA:NK (3/20/2026, 7:00:00 PM)

20.68

-0.34 (-1.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-19
Earnings (Next)07-27
Inst Owners67.87%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap1.76B
Revenue(TTM)3.38B
Net Income(TTM)-408.80M
Analysts77.14
Price Target27.2 (31.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.57%
Yearly Dividend1.46
Dividend Growth(5Y)-2.74%
DP-30.16%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.84%
PT rev (3m)-3.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.01%
EPS NY rev (3m)-3.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.83
P/S 0.52
P/FCF 15.45
P/OCF 4.05
P/B 0.68
P/tB 1.98
EV/EBITDA 5.16
EPS(TTM)-4.85
EYN/A
EPS(NY)2.1
Fwd EY10.18%
FCF(TTM)1.34
FCFY6.47%
OCF(TTM)5.1
OCFY24.67%
SpS39.84
BVpS30.62
TBVpS10.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.64%
ROE -15.72%
ROCE 4.28%
ROIC 3.13%
ROICexc 3.72%
ROICexgc 6.02%
OM 6.7%
PM (TTM) N/A
GM 67.02%
FCFM 3.36%
ROA(3y)-2.45%
ROA(5y)-0.22%
ROE(3y)-5.66%
ROE(5y)-0.47%
ROIC(3y)3.45%
ROIC(5y)3.92%
ROICexc(3y)4.14%
ROICexc(5y)4.54%
ROICexgc(3y)7.45%
ROICexgc(5y)7.98%
ROCE(3y)4.71%
ROCE(5y)5.36%
ROICexgc growth 3Y-11.58%
ROICexgc growth 5Y-7.44%
ROICexc growth 3Y-11.92%
ROICexc growth 5Y-4.07%
OM growth 3Y-12.06%
OM growth 5Y-4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.57%
GM growth 5Y2.71%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 19.65
Debt/EBITDA 4.09
Cap/Depr 105.13%
Cap/Sales 9.45%
Interest Coverage 3.45
Cash Conversion 81.64%
Profit Quality N/A
Current Ratio 2.46
Quick Ratio 1.64
Altman-Z 1.69
F-Score6
WACC6.51%
ROIC/WACC0.48
Cap/Depr(3y)122.92%
Cap/Depr(5y)121.99%
Cap/Sales(3y)10.22%
Cap/Sales(5y)10.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-323.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.65%
EPS Next Y16.63%
EPS Next 2Y13.54%
EPS Next 3Y19.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-7.55%
Revenue growth 5Y-2.29%
Sales Q2Q%-3.51%
Revenue Next Year3.08%
Revenue Next 2Y2.87%
Revenue Next 3Y3.78%
Revenue Next 5Y7.26%
EBIT growth 1Y-18.27%
EBIT growth 3Y-18.69%
EBIT growth 5Y-6.28%
EBIT Next Year120.2%
EBIT Next 3Y37.72%
EBIT Next 5YN/A
FCF growth 1Y13.93%
FCF growth 3YN/A
FCF growth 5Y-16.18%
OCF growth 1Y-8.93%
OCF growth 3Y14.02%
OCF growth 5Y-4.24%

IMERYS SA / NK.PA Fundamental Analysis FAQ

What is the fundamental rating for NK stock?

ChartMill assigns a fundamental rating of 3 / 10 to NK.PA.


Can you provide the valuation status for IMERYS SA?

ChartMill assigns a valuation rating of 4 / 10 to IMERYS SA (NK.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for IMERYS SA?

IMERYS SA (NK.PA) has a profitability rating of 3 / 10.


How financially healthy is IMERYS SA?

The financial health rating of IMERYS SA (NK.PA) is 3 / 10.


Is the dividend of IMERYS SA sustainable?

The dividend rating of IMERYS SA (NK.PA) is 3 / 10 and the dividend payout ratio is -30.16%.